#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13850	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2078	663.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1442	1442	C	897	C	814	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13850	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2078	663.3	0	HET	.	.	.	C207T	.	207	207	C	465	465	C	746	C,T	535,150	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25500	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3496	726.7	0	.	n	.	0	T695C	SNP	695	695	T	1021	1021	C	802	C	739	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25500	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3496	726.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	1964	1964	G	774	G	730	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25500	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3496	726.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2297	2297	C	793	C	738	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25500	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3496	726.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2371	2371	A	796	A	741	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25500	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3496	726.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2923	2923	C	789	C	725	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1664	folP	855	855	100.0	folP.l15.c4.ctg.1	1549	107.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1090	1092	AGC	177;171;168	A;G;C	160;155;152	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4782	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3414	139.7	1	SNP	p	S91F	1	.	.	271	273	TTC	542	544	TTC	178;177;178	T;T,C;C	163;164,1;167	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4782	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3414	139.7	1	SNP	p	D95G	1	.	.	283	285	GGC	554	556	GGC	167;166;167	G,T;G,A;C	149,1;150,1;151	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4782	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3414	139.7	1	SNP	p	G95N	0	.	.	283	285	GGC	554	556	GGC	167;166;167	G,T;G,A;C	149,1;150,1;151	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1504	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1466	102.5	1	SNP	p	G45D	0	.	.	133	135	GGC	619	621	GGC	192;193;194	G,A;G;C	177,1;180;180	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	762	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	978	76.9	0	.	n	.	0	A197.	DEL	197	197	A	456	456	A	187	A	175	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5550	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3011	183.6	1	SNP	p	D86N	0	.	.	256	258	GAC	554	556	GAC	204;203;201	G;A;C	196;190;192	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5550	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3011	183.6	1	SNP	p	R87I	0	.	.	259	261	CGT	557	559	CGT	205;204;207	C;G,A;T	195;194,1;194	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5550	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3011	183.6	1	SNP	p	S87R	1	.	.	259	261	CGT	557	559	CGT	205;204;207	C;G,A;T	195;194,1;194	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5550	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3011	183.6	1	SNP	p	R87W	0	.	.	259	261	CGT	557	559	CGT	205;204;207	C;G,A;T	195;194,1;194	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5550	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3011	183.6	1	SNP	p	S88P	0	.	.	262	264	TCC	560	562	TCC	208;211;213	T;C,A;C	195;196,1;202	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3660	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2579	141.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1518	1520	GGC	204;205;205	G;G;C	190;189;191	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3610	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2522	142.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1374	1376	GCC	201;197;199	G;C;C	184;184;187	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3610	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2522	142.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1377	1379	ATG	202;205;202	A;T;G	190;192;190	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3610	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2522	142.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1389	1391	ACC	210;209;213	A;C,A;C,A	188;189,1;189,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3610	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2522	142.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1389	1391	ACC	210;209;213	A;C,A;C,A	188;189,1;189,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3610	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2522	142.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1890	1892	ACC	186;187;190	A;C;C	172;173;178	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3610	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2522	142.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1944	1946	GCG	207;206;205	G;C;G,A	194;193;192,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3610	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2522	142.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1944	1946	GCG	207;206;205	G;C;G,A	194;193;192,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3610	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2522	142.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2067	2069	GGT	173;169;170	G;G;T	163;162;158	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3610	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2522	142.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2076	2078	AGC	167;167;169	A;G;C	157;155;156	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3610	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2522	142.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2094	2096	CCG	152;161;164	C,G,A;C;GCCC,GGCCCC	113,3,1;124;118,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5568	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3121	177.8	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1605	1607	CCG	193;190;188	C;C;G	172;174;168	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2262	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1807	124.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	559	559	C	167	C	152	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2802	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1664	167.8	0	.	p	.	0	G210R	NONSYN	628	630	GGA	986	988	AGA	229;225;227	A;G;A	220;214;216	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2802	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1664	167.8	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1007	1009	GGT	226;224;224	G;G;T	220;219;218	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2802	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1664	167.8	1	SNP	p	G120K	1	.	.	358	360	AAG	716	718	AAG	233;227;228	A;A;G,T	216;212;209,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2802	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1664	167.8	1	SNP	p	A121N	1	.	.	361	363	AAC	719	721	AAC	226;228;226	A,G;A;C	208,1;211;211	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2802	porB1b	1038	1038	99.81	porB1b.l6.c4.ctg.1	1664	167.8	1	SNP	p	N121D	0	.	.	361	363	AAC	719	721	AAC	226;228;226	A,G;A;C	208,1;211;211	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10254	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4738	215.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1072	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1120	95.7	1	SNP	p	V57M	1	.	.	169	171	ATG	570	572	ATG	239;238;238	A;T;G	222;220;220	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
